Feasibility of quantitative sensory testing (QST) in clinical routine as a tool to evaluate chemotherapy-induced peripheral neuropathy (CIPN) amongst breast cancer patients treated with taxanes

Subjects

Subjects :

Oncology
medicine.medical_specialty
Breast cancer
Chemotherapy-induced peripheral neuropathy
business.industry
Internal medicine
Quantitative sensory testing
Medicine
Hematology
business
medicine.disease
Clinical routine

Details

ISSN :

09237534

Volume :

30

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........108619007d4a3e60722046e50a6306b1

Full Text :

https://doi.org/10.1093/annonc/mdz101.018